trimetrexate , a highly lipid-soluble quinazoline antifolate now undergoing trials as an anticancer agent , was found to be a potent inhibitor of the dihydrofolate reductase ( dhfr ) isolated from toxoplasma gondii .
C0085176
trimetrexate
C0034407
quinazoline